Additionally, DFS analysis showed that patients with ACC (P = 7 × 10–4), LGG (P = 0.032), and MESO (P = 0.044) had worse outcomes if their SLC31A1 levels were higher, while patients with KIRC (P = 6.7 × 10–6) and STAD (P = 0.02) in 5 years had lower levels (Fig. 3). The gene discussed is SLC31A1; the disease is adrenal cortex carcinoma.